EUVIMEDEUVIMED entdecken
Crossref

Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma Group

Gilles Achard, Céline Charon-Barra, Sebastien Carrere, Sylvie Bonvalot, Pierre Meeus, Magali Fau, Charles Honoré, Jean-Baptiste Delhorme, Dimitri Tzanis, François Le Loarer, Marie Karanian-Philippe, Carine Ngo und 4 weitere

European Journal of Surgical Oncology · 2023-07 · 49 (7) · 1203-1208

DOI: 10.1016/j.ejso.2023.02.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2023-07. Verfasst von Gilles Achard und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Centre Georges-François Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France. Hauptthemen laut MEDLINE: Spermatic Cord, Sarcoma, Liposarcoma, Leiomyosarcoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the outcomes of adult patients with spermatic cord sarcoma (SCS). METHODS: All consecutive patients with SCS managed by the French Sarcoma Group from 1980 to 2017 were analysed retrospectively. Multivariate analysis (MVA) was used to identify independent correlates of overall survival (OS), metastasis-free survival (MFS), and local relapse-free survival (LRFS). RESULTS: A total of 224 patients were recorded. The median age was 65.1 years. Forty-one (20.1%) SCSs were discovered unexpectedly during inguinal hernia surgery. The most common subtypes were liposarcoma (LPS) (73%) and leiomyosarcoma (LMS) (12.5%). The initial treatment was surgery for 218 (97.3%) patients. Forty-two patients (18.8%) received radiotherapy, 17 patients (7.6%) received chemotherapy. The median follow-up was 5.1 years. The median OS was 13.9 years. In MVA, OS decreased significantly with histology (HR, well-differentiated LPS versus others = 0.096; p = 0.0224), high grade (HR, 3 versus 1-2 = 2.7; p = 0.0111), previous cancer and metastasis at diagnosis (HR = 6.8; p = 0.0006). The five-year MFS was 85.9% [95% CI: 79.3-90.6]. In MVA, significant factors associated with MFS were LMS subtype (HR = 4.517; p < 10-4) and grade 3 (HR = 3.664; p < 10-3). The five-year LRFS survival rate was 67.9% [95% CI: 59.6-74.9]. In MVA, significant factors associated with local relapse were margins and wide reresection (WRR) after incomplete resection. OS was not significantly different between patients with initial R0/R1 resection and R2 patients who underwent WRR. CONCLUSIONS: Unplanned surgery affected 20.1% of SCSs. A nonreducible painless inguinal lump should suggest a sarcoma. WRR with R0 resection achieved similar OS to patients with correct surgery upfront.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spermatic CordSarcomaLiposarcomaLeiomyosarcomaSoft Tissue NeoplasmsMaleAdultHumansAgedPrognosisRetrospective StudiesLipopolysaccharidesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Sarcoma unplained excisionSpermatic cord sarcomaSurgeryTreatment

Substanzen

Lipopolysaccharides

Autor:innen und Institutionen

  • Department of Pathology, Centre Georges-François Leclerc, 1 Rue du Professeur Marion, 21000, Dijon, France.
  • Department of Surgery, Institut du Cancer de Montpellier, 208 rue des Apothicaires, 34298, Montpellier, France.
  • Department of Surgery, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France. Electronic address: sylvie.bonvalot@curie.fr.
  • Department of Surgery, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008, Lyon, France.
  • Department of Surgery, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France.
  • Department of Surgery, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France.

Zitieren

APA

Achard, G., Charon-Barra, C., Carrere, S., Bonvalot, S., Meeus, P., Fau, M., Honoré, C., Delhorme, J. B., Tzanis, D., Le Loarer, F., Karanian-Philippe, M., Ngo, C., Le Guellec, S., Bertaut, A., Causeret, S., & Isambert, N. (2023). Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma Group. European Journal of Surgical Oncology, 49(7), 1203-1208. https://doi.org/10.1016/j.ejso.2023.02.013

Vancouver

Achard G, Charon-Barra C, Carrere S, Bonvalot S, Meeus P, Fau M, et al. Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma Group. European Journal of Surgical Oncology. 2023;49(7):1203-1208. doi:10.1016/j.ejso.2023.02.013

BibTeX
@article{Achard2023,
  author = {Achard, Gilles and Charon-Barra, Céline and Carrere, Sebastien and Bonvalot, Sylvie and Meeus, Pierre and Fau, Magali and Honoré, Charles and Delhorme, Jean-Baptiste and Tzanis, Dimitri and Le Loarer, François and Karanian-Philippe, Marie and Ngo, Carine and Le Guellec, Sophie and Bertaut, Aurélie and Causeret, Sylvain and Isambert, Nicolas},
  title = {Prognostic factors and outcomes of adult spermatic cord sarcoma. A study from the French Sarcoma Group},
  journal = {European Journal of Surgical Oncology},
  year = {2023},
  volume = {49},
  number = {7},
  pages = {1203--1208},
  doi = {10.1016/j.ejso.2023.02.013}
}
Kostenlos starten →